Table 1 Baseline Characteristics.
From: Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab
Parameter | |
|---|---|
Eyes/patients | 80/74 |
Age (years) | 69 (60–73) |
Men/women | 41/33 |
Hemoglobin A1c (%) | 7.1 (6.7–7.8) |
Systemic hypertension (patients) | 45 |
LogMAR VA | 0.260 (0.155–0.523) |
International classification | |
Mild NPDR | 1 eye |
Moderate NPDR | 47 eyes |
Severe NPDR | 15 eyes |
PDR | 17 eyes |
Pseudophakia | 28 eyes |
Panretinal photocoagulation | 50 eyes |
CSF thickness (μm) | 445 (393–545) |
Cystoid abnormalities | 67 eyes (Kappa coefficient = 1.000) |
Subretinal fluid | 19 eyes (Kappa coefficient = 1.000) |
Vitreoretinal abnormalities | 5 eyes (Kappa coefficient = 0.882) |
Disrupted EZ line (%) | 9.6 (0.0–28.0) (ICC = 0.944) |
Hyperreflective foci in the inner retinal layers | 65 eyes (Kappa coefficient = 0.843) |
Hyperreflective foci in the outer retinal layers | 43 eyes (Kappa coefficient = 0.875) |
